NCT00152451View on ClinicalTrials.gov

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 19, 2005

Primary Completion Date

May 3, 2006

Study Completion Date

May 3, 2006

Conditions
Epilepsy, Partial
Interventions
DRUG

Seletracetam (ucb 44212)

"* Pharmaceutical form: oral capsules~* Concentration: 10 and 50 mg~* Route of administration: oral administration"

Trial Locations (7)

19104

N01191 104, Philadelphia

22903

N01191 103, Charlottesville

37212

N01191 101, Nashville

43210

N01191 107, Columbus

72205

N01191 108, Little Rock

94115

N01191 105, San Francisco

94305

N01191 102, Stanford

All Listed Sponsors
lead

UCB S.A. - Pharma Sector

INDUSTRY

NCT00152451 - Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures | Biotech Hunter | Biotech Hunter